Back to search

Article

Inhibition of CGRP receptor ameliorates AD pathology by reprogramming lipid metabolism through HDAC11/LXRβ/ABCA1 signaling

2026-04-21

Abstract excerpt

<title>Abstract</title> <p>The Calcitonin gene-related peptide (CGRP) receptor has gained attention in Alzheimer’s Disease (AD) research due to its involvement in regulating neuroinflammation, but its role and mechanism in AD pathology remain unclear. Here, we demonstrate that CALCRL, a core component of the CGRP receptor, is upregulated in the hippocampus of AD dementia patients and 5×FAD mice. Knockout of the C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0be69b8c-c5aa-5380-acb4-729db4db8dec
DOI
10.21203/rs.3.rs-9358637/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of CGRP receptor ameliorates AD pathology by reprogramming lipid metabolism through HDAC11/LXRβ/ABCA1 signalingDOI 10.21203/rs.3.rs-9358637/v1
Select a neighboring publication to make it the new centre.